T2DM can impede NO-mediated vasorelaxation induced by RBCs [26] and hinder cardiac post-ischemic recovery through an RBC arginase-dependent modulation of eNOS and ROS in mice [24]. The gene discussed is NOS3; the disease is type 2 diabetes mellitus.